Brain, Vol. 123, No. 9, 1830-1837,
September 2000
© 2000 Oxford University Press
Nitric oxide-induced headache in patients with chronic tension-type headache
Department of Neurology, Glostrup Hospital, University of Copenhagen, DK-2600 Glostrup, Copenhagen, Denmark
Correspondence to:
Messoud Ashina, Department of Neurology, Glostrup Hospital, University of Copenhagen, DK-2600 Glostrup, Copenhagen, Denmark E-mail: ashina{at}dadlnet.dk
An experimental model of headache offers unique possibilities to study the mechanisms responsible for head pain. Using the glyceryl trinitrate [GTN; nitric oxide (NO) donor] model of experimental headache, we studied the intensity, quality and time profile of headache after infusion of GTN in 16 patients with chronic tension-type headache and in 16 healthy controls. Subjects were randomized to receive intravenous infusion of GTN (0.5 µg/kg per minute for 20 min) or placebo on two headache-free days separated by at least 1 week. Headache intensity was measured on a 10-point verbal rating scale during 2 h of observation and for the next 10 h after discharge from hospital. The primary endpoints were the difference between the area under the curve (AUC—intensities x duration) for headache recorded on the day of GTN treatment and on the day of placebo treatment in patients, and in patients and controls on the days of GTN treatment. In patients, the AUC on a GTN day [2221 (1572–3704); median with quartiles in paren- theses], was significantly greater than on a placebo day [730 (60–1678), P = 0.008]. On the GTN day, the AUC in patients [2221 (1572–3704)] was significantly higher than in controls [43 (0–972), P = 0.0001]. In patients, peak pain intensity occurred 8 h after infusion of GTN, whereas in controls it occurred 20 min after the start of infusion. The present study demonstrates that an NO-induced biphasic response with an immediate and a delayed headache is common to chronic tension-type headache and migraine. Furthermore, the NO-induced delayed headache has the characteristics of the primary headache disorder. This suggests that NO contributes to the mechanisms of several types of primary headaches and that NO-related central sensitization may be an important common denominator in the pain mechanisms of primary headaches.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Schlechtweg, J Roder, M. Fischer, W Neuhuber, and K Messlinger Increase in NADPH-Diaphorase-Positive and Neuronal NO Synthase Immunoreactive Neurons in the Rat Spinal Trigeminal Nucleus Following Infusion of a NO Donor--Evidence for a Feed-Forward Process in NO Production Involved in Trigeminal Nociception Cephalalgia, May 1, 2009; 29(5): 566 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Kulchitsky, M. Fischer, and K Messlinger Calcitonin Gene-Related Peptide Receptor Inhibition Reduces Neuronal Activity Induced by Prolonged Increase in Nitric Oxide in the Rat Spinal Trigeminal Nucleus Cephalalgia, April 1, 2009; 29(4): 408 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Schytz, T Wieneckey, P. Oturai, J Olesen, and M Ashina The Cholinomimetic Agent Carbachol Induces Headache in Healthy Subjects Cephalalgia, February 1, 2009; 29(2): 258 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hansen, L. Thomsen, R Marconi, G Casari, J Olesen, and M Ashina Familial Hemiplegic Migraine Type 2 does not Share Hypersensitivity to Nitric Oxide with Common Types of Migraine Cephalalgia, April 1, 2008; 28(4): 367 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Magis, L Bendtsen, P. Goadsby, A May, M S. d. Rio, P. Sandor, H Kaube, G Sandrini, G. Schoonman, J Schoenen, et al. Evaluation and Proposal for Optimization of Neurophysiological Tests In Migraine: Part 2--Neuroimaging and The Nitroglycerin Test Cephalalgia, December 1, 2007; 27(12): 1339 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Schwenger, M Dux, R d. Col, R Carr, and K Messlinger Interaction of Calcitonin Gene-Related Peptide, Nitric Oxide and Histamine Release in Neurogenic Blood Flow and Afferent Activation in The Rat Cranial Dura Mater Cephalalgia, June 1, 2007; 27(6): 481 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Benoliel, J. Epstein, E. Eliav, R. Jurevic, and S. Elad Orofacial Pain in Cancer: Part I--Mechanisms Journal of Dental Research, June 1, 2007; 86(6): 491 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Pardutz, Z Hoyk, H Varga, L Vecsei, and J Schoenen Oestrogen-Modulated Increase of Calmodulin-Dependent Protein Kinase II (CamKII) in Rat Spinal Trigeminal Nucleus After Systemic Nitroglycerin Cephalalgia, January 1, 2007; 27(1): 46 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Sandrini, P Rossi, I Milanov, M Serrao, A. Cecchini, and G Nappi Abnormal Modulatory Influence of Diffuse Noxious Inhibitory Controls in Migraine and Chronic Tension-Type Headache Patients Cephalalgia, July 1, 2006; 26(7): 782 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Ashina, H Simonsen, L Bendtsen, R Jensen, and J Olesen Glyceryl Trinitrate may Trigger Endogenous Nitric Oxide Production in Patients with Chronic Tension-Type Headache Cephalalgia, November 1, 2004; 24(11): 967 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Levy and A. M. Strassman Modulation of Dural Nociceptor Mechanosensitivity by the Nitric Oxide-Cyclic GMP Signaling Cascade J Neurophysiol, August 1, 2004; 92(2): 766 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Pardutz, E Szatmari, L Vecsei, and J Schoenen Nitroglycerin-Induced nNOS Increase in Rat Trigeminal Nucleus Caudalis is Inhibited by Systemic Administration of Lysine Acetylsalicylate but not of Sumatriptan Cephalalgia, June 1, 2004; 24(6): 439 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Ashina Neurobiology of Chronic Tension-Type Headache Cephalalgia, March 1, 2004; 24(3): 161 - 172. [Full Text] [PDF]
|
|
|
|
|
|
G Sances, C Tassorelli, E Pucci, N Ghiotto, G Sandrini, and G Nappi Reliability of the Nitroglycerin Provocative Test in the Diagnosis of Neurovascular Headaches Cephalalgia, February 1, 2004; 24(2): 110 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Jensen Peripheral and Central Mechanisms in Tension-Type Headache: an Update Cephalalgia, May 1, 2003; 23(1_suppl): 49 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V Gallai, A Alberti, B Gallai, F Coppola, A Floridi, and P Sarchielli Glutamate and Nitric Oxide Pathway in Chronic Daily Headache: Evidence From Cerebrospinal Fluid Cephalalgia, April 1, 2003; 23(3): 166 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Jensen Mechanisms of Tension-Type Headache Cephalalgia, September 1, 2001; 21(7): 786 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Ashina, L Bendtsen, R Jensen, F Sakai, and J Olesen Possible Mechanisms of Glyceryl-Trinitrate-Induced Immediate Headache in Patients With Chronic Tension-Type Headache Cephalalgia, December 1, 2000; 20(10): 919 - 924. [Abstract] [Full Text] [PDF]
|
|